Multimometer - Vital Signs Device for Diagnosis of Pneumonia

NCT ID: NCT03265756

Last Updated: 2018-11-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

350 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-06-20

Study Completion Date

2018-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Pneumonia is a major cause of illness in young children. The investigators are developing and testing a new thermometer like device called Multimometer, to measure the respiration rate (RR), temperature, heart rate (HR) and the degree of blood oxygenation (SpO2) of children who may suffer from pneumonia. These are called vital signs and their measurements greatly help to diagnose pneumonia.

In the first part of the study, and in order to optimize and better align the size of the device with the face, the investigators will measure the average size and dimensions of young children's face. In the second part of the study, the investigators will compare the vital signs measurements with measurements obtained by other commonly used devices in ill children who are suspected to suffer from pneumonia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A. Improve the universality of the mouth-interface using facial anthropometry techniques.

For this first part of the study, the investigators will use a portable 3D camera (as previously used by our group) to acquire 250 3D facial images of healthy children under 5yrs of age in the DRC. While in hospital/clinic, the investigators will use a three-dimension (3D) special camera to obtain an image of the child's face. The child can sit on the lap of the parent and we will take the image. The image acquisition takes less than 30 seconds. There are no specific requirements from the child, and the image can be taken if the child is asleep or awake, cry or settled. No medical or identifying information will be collected.

All the computerized images will be cluster analyzed (using previously established methodologies from the Technion, Israel) and three 3D average faces of all small, medium and large faces will be constructed. The investigators will use these "faces" to design better Multimometers with improved mouth-interface for this population.

B. Integrate into the current device a reflexive pulse oximeter sensor which will allow measurements of oxygen saturation and heart rate.

For the addition of HR and SpO2 measurements, the investigators will integrate a reflective pulse oximetry chip into the probe. Together with the manufacturer (RespiDx Inc., Israel) the investigators will design and manufacture optimal prototype devices suitable for performing clinical trials on this population.

C. Compare vital signs measurements by Multimometer® to simultaneous vital signs measurement using conventional devices.

For this part of the study, repeated (x5 times) measurements of the 4 vital signs in 50 young children (under 5 yrs) in hospital/clinics in Butembo DRC with suspected pneumonia, will be recorded using the Multimometer. These signs will also be measured at the same time, by conventional methods (regular thermometers for temperature, observed respiratory rate using recorded chest movements and end-tidal carbon dioxide (CO2) for respiratory rate, standard pulse oximeters for oxygen saturation and heart rate). All these measurements take less than 5 minutes. The investigators will repeat these sets approximately 5 times during the same day in the hospital or during a clinic visit. The vital signs will be compared between the two methods using Pearson's correlation coefficient and using Bland-Altman plots for agreement.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy children

250 3D facial images of healthy children under 5yrs of age in the Democratic Republic of Congo (DRC).

No interventions assigned to this group

Suspected Pneumonia

50 young children (under 5 yrs) in hospital/clinics in Butembo DRC with suspected pneumonia

Multimometer

Intervention Type DEVICE

A device for measuring respiration rate, temperature, heart rate and the degree of blood oxygenation of children

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Multimometer

A device for measuring respiration rate, temperature, heart rate and the degree of blood oxygenation of children

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

For the first part of the study (3D facial images):

• Healthy children under 5y of age

For the second phase of the study (Comparison of vital signs):

• Children under 5y of age with suspected pneumonia

Exclusion Criteria

• Children older than 5y of age
Maximum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Grand Challenges Canada

OTHER

Sponsor Role collaborator

University of Alberta

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Israel Amirav

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Israel Amirav

Role: PRINCIPAL_INVESTIGATOR

University of Alberta

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alberta

Edmonton, Alberta, Canada

Site Status

AHFIA (Association for Health Innovation in Africa)

Butembo, North Kivu, Democratic Republic of the Congo

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada Democratic Republic of the Congo

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pro00072555

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The PneumoRator Study
NCT07293299 RECRUITING